Q3 FY2025 Earnings
Financial report interval: 2025.06.30 - 2025.09.30
Overview: ITERUM THERAPEUTICS PLC(ITRMF) the Revenue is 390 K (--%), Beat estimate;the EBIT is -7.731 M (-58.2%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B--
0.00B--
+0.00B--%
EBIT
-0.01B58.20%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf